Insider · CIK 0001266748

CMEA VENTURES VI LP

Reports to the SEC for 2 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001266748

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-11-10	INTERMOLECULAR INCS Sale	Director, 10% Owner	SSale	−4.38M sh	$2.20	−$9.63M	0
2014-11-10	INTERMOLECULAR INCS Sale	Director, 10% Owner	SSale	−104K sh	$2.20	−$230K	0
2013-09-18	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−2,335 sh	$10.20	−$23.8K	47,992
2013-09-18	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−97.7K sh	$10.20	−$996K	2,007,246
2013-09-17	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−192 sh	$9.48	−$1,820.16	50,327
2013-09-17	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−8,012 sh	$9.48	−$76K	2,104,911
2013-09-16	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−1,057 sh	$9.22	−$9,745.54	50,519
2013-09-16	TETRAPHASE PHARMACEUTICALS INCS Sale	10% Owner	SSale	−44.2K sh	$9.22	−$408K	2,112,923
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+982K sh	—	—	1,529,059
2013-03-25	TETRAPHASE PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+628K sh	$7.00	+$4.4M	2,157,130
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-1 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−49.1K sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-1 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−2.04M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-2 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−64K sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries A-2 Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−2.66M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries B Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−268K sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries B Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−11.2M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries C Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−686K sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCSeries C Convertible Participating Preferred StockC Conversion	10% Owner	CConversion	−28.5M sh	—	—	0
2013-03-25	TETRAPHASE PHARMACEUTICALS INCP Purchase	10% Owner	PPurchase	+14.8K sh	$7.00	+$104K	51,576
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+1,693 sh	—	—	1,693
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+70.4K sh	—	—	70,376
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+2,208 sh	—	—	3,901
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+91.8K sh	—	—	162,171
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+9,250 sh	—	—	13,151
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+385K sh	—	—	546,784
2013-03-25	TETRAPHASE PHARMACEUTICALS INCC Conversion	10% Owner	CConversion	+23.6K sh	—	—	36,790
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+1.92M sh	—	—	1,923,912
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+3.66M sh	—	—	5,587,615
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+998K sh	—	—	6,585,986
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+496K sh	—	—	7,081,489
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+294K sh	—	—	7,375,500
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+44.8K sh	—	—	44,798
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+86.2K sh	—	—	131,047
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+23.4K sh	—	—	154,436
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+11.6K sh	—	—	166,049
2011-11-23	INTERMOLECULAR INCC Conversion	Director, 10% Owner	CConversion	+6,894 sh	—	—	172,943
2011-11-23	INTERMOLECULAR INCSeries A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.85M sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−89.6K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−7.33M sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−172K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2M sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−46.8K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−991K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries D Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−23.2K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries E Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−588K sh	—	—	0
2011-11-23	INTERMOLECULAR INCSeries E Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−13.8K sh	—	—	0

Recent filings

Accepted (ET)
Nov 124
INTERMOLECULAR INC0001209191-14-068129
SEC(opens sec.gov)
Sep 204
TETRAPHASE PHARMACEUTICALS INC0001012975-13-000448
SEC(opens sec.gov)
Sep 184
TETRAPHASE PHARMACEUTICALS INC0001012975-13-000443
SEC(opens sec.gov)
Mar 274
CMEA VENTURES VI LP0001181431-13-019231
SEC(opens sec.gov)

Companies

Address

ONE LETTERMAN DRIVE BUILDING C, SUITE CM500

SAN FRANCISCO, CA, 94129-2402